Umedical

UMEDICA, a part of the Amoli Group of Companies, is a leading manufacturer and exporter of a wide range of pharmaceutical formulations including Injectables, Tablets, Capsules, Suspensions, Dry Syrups, and more. The company’s product portfolio includes antibiotics, anti-diabetics, anti-hyperlipidemic, anti-hypertensives, non-steroidal anti-inflammatory drugs (NSAIDs), analgesics, antifungal, anti-malarial, antihistaminic, psychotropic, diuretics, drugs for sexual dysfunction, and multivitamins, among others, with a patient-centric approach.

UMEDICA is committed to a culture of innovation and continuous improvement, aiming to achieve more in the pharmaceutical industry. The company’s manufacturing facility, located in Vapi, Gujarat, is approved by WHO GMP, US FDA, EU, Health Canada, TGA, and UAE MoH, and has also been audited and approved by regulatory authorities of various countries around the world, including the USA, EU, Australia, Canada, UAE, Zimbabwe, Ethiopia, Tanzania, Nigeria, Uganda, Kenya, Ghana, Ivory Coast, Malawi, and more.

UMEDICA’s manufacturing capabilities are supported by a dedicated R&D Centre staffed with qualified and experienced scientists, who work on improving existing products and developing new formulations to meet the changing needs of patients and the market. The company also has a team of regulatory affairs specialists who are well-versed with international regulatory policies and procedures, ensuring compliance with global regulatory requirements.